STRATA Operating Cash Flow Sales Ratio from 2010 to 2025

SSKN Stock  USD 2.76  0.09  3.37%   
STRATA Skin Operating Cash Flow Sales Ratio yearly trend continues to be very stable with very little volatility. Operating Cash Flow Sales Ratio is likely to drop to -0.01. During the period from 2010 to 2025, STRATA Skin Operating Cash Flow Sales Ratio quarterly data regression pattern had sample variance of  778.15 and median of (0.01). View All Fundamentals
 
Operating Cash Flow Sales Ratio  
First Reported
2010-12-31
Previous Quarter
(0.01)
Current Value
(0.01)
Quarterly Volatility
27.89542841
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check STRATA Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among STRATA Skin's main balance sheet or income statement drivers, such as Total Revenue of 19.5 M, Gross Profit of 11.1 M or Other Operating Expenses of 47.9 M, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0 or PTB Ratio of 1.43. STRATA financial statements analysis is a perfect complement when working with STRATA Skin Valuation or Volatility modules.
  
Check out the analysis of STRATA Skin Correlation against competitors.

Latest STRATA Skin's Operating Cash Flow Sales Ratio Growth Pattern

Below is the plot of the Operating Cash Flow Sales Ratio of STRATA Skin Sciences over the last few years. It is STRATA Skin's Operating Cash Flow Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in STRATA Skin's overall financial position and show how it may be relating to other accounts over time.
Operating Cash Flow Sales Ratio10 Years Trend
Slightly volatile
   Operating Cash Flow Sales Ratio   
       Timeline  

STRATA Operating Cash Flow Sales Ratio Regression Statistics

Arithmetic Mean(16.42)
Geometric Mean0.39
Coefficient Of Variation(169.93)
Mean Deviation22.57
Median(0.01)
Standard Deviation27.90
Sample Variance778.15
Range69.1671
R-Value0.79
Mean Square Error310.71
R-Squared0.63
Significance0.0003
Slope4.64
Total Sum of Squares11,672

STRATA Operating Cash Flow Sales Ratio History

2025 -0.0147
2024 -0.014
2023 -0.0156
2022 -0.0306
2021 0.0503
2020 0.0908
2019 0.0706

About STRATA Skin Financial Statements

STRATA Skin investors utilize fundamental indicators, such as Operating Cash Flow Sales Ratio, to predict how STRATA Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cash Flow Sales Ratio(0.01)(0.01)
When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:
Check out the analysis of STRATA Skin Correlation against competitors.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.60)
Revenue Per Share
8.978
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.09)
Return On Equity
(0.73)
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.